Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11633408 | Prevention of adverse effects caused by CD3 specific binding domains | Gerhard Zugmaier, Juergen Scheele | 2023-04-25 |
| 11579142 | Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at risk for potential adverse effects | — | 2023-02-14 |
| 11084876 | Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains | Peter Kufer, Juergen Scheele, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more | 2021-08-10 |
| 10696744 | Means and methods for treating DLBCL | Gerhard Zugmaier, Juergen Scheele | 2020-06-30 |
| 10662243 | Dosage regimen for administering a CD19XCD3 bispecific antibody | Peter Kufer, Gerhard Zugmaier, Patrick Bauerle | 2020-05-26 |
| 10191034 | Dosage regimen for administrating a CD19×CD3 bispecific antibody to patients at risk for potential adverse effects | — | 2019-01-29 |
| 10130638 | Prevention of adverse effects caused by CD3 specific binding domains | Gerhard Zugmaier, Juergen Scheele | 2018-11-20 |
| 9688760 | Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains | Peter Kufer, Juergen Scheele, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more | 2017-06-27 |
| 9486475 | PPS for the prevention of potential adverse effects caused by CD3 specific binding domains | Peter Kufer, Juergen Scheele, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more | 2016-11-08 |
| 9192665 | Means and methods for treating DLBCL | Gerhard Zugmaier, Juergen Scheele | 2015-11-24 |
| 8840888 | Dosage regimen for administering a CD19XCD3 bispecific antibody | Peter Kufer, Gerhard Zugmaier, Patrick Baeuerle | 2014-09-23 |